aica ribonucleotide has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, B; Gao, L; Guan, Q; Guo, H; Sun, N; Tian, L; Wang, L; Zhang, X; Zhao, J | 1 |
| Chadid, S; Deoliveira, R; Eddy, VJ; Persons, KS; Ray, R; Saha, AK | 1 |
2 other study(ies) available for aica ribonucleotide and Pancreatic Neoplasms
| Article | Year |
|---|---|
AMP-activated protein kinase and pancreatic/duodenal homeobox-1 involved in insulin secretion under high leucine exposure in rat insulinoma beta-cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Death; Cell Line, Tumor; Enzyme Inhibitors; Glucokinase; Glucose Transporter Type 2; Homeodomain Proteins; Insulin; Insulin Secretion; Insulin-Secreting Cells; Insulinoma; Leucine; Pancreatic Neoplasms; Rats; Ribonucleotides; Trans-Activators | 2009 |
Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells.
Topics: Acetyl-CoA Carboxylase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Calcitriol; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; Drug Therapy, Combination; Humans; Pancreatic Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribonucleotides; Tumor Suppressor Protein p53 | 2010 |